DEFA14A: Rhythm Pharmaceuticals Postpones Annual Meeting Due to Technical Error

Rhythm Pharmaceuticals has postponed its 2024 annual meeting to September 18, 2024, due to a technical error in the record date used for the broker search.

Summary

• Rhythm Pharmaceuticals announced the postponement of its 2024 annual meeting of stockholders from June 18, 2024, to September 18, 2024.
• The postponement is attributed to a technical error in the record date used for the broker search.
• A new record date of July 24, 2024, has been approved by the Board.
• Preliminary voting reports indicated sufficient votes for a quorum and passage of all proposals based on the incorrect record date.
• The Board decided to postpone the meeting to ensure all stockholders of record receive proxy materials.
• No changes have been made to the proposals to be considered at the Annual Meeting.
• The deadline for stockholders to submit business proposals or director nominations is June 27, 2024.
• Stockholder proposals for inclusion in the proxy statement must also be received by June 27, 2024.

Sentiment

Score: 6

Explanation: The announcement is neutral, detailing a procedural delay. While the delay itself isn't positive, the company is addressing the issue and ensuring all stockholders can participate.

Positives

• Preliminary voting reports suggest that a quorum would have been achieved and all proposals would have passed with the incorrect record date, indicating strong stockholder support.

Negatives

• The postponement of the Annual Meeting may cause inconvenience for stockholders.

Risks

• The technical error in the record date could raise concerns about the company's internal controls.

Future Outlook

The Company intends to file updated proxy materials for the Annual Meeting with the Securities and Exchange Commission and mail such materials to stockholders of record as of the newly established record date.

Management Comments

• The Board has determined to postpone the Annual Meeting and establish a new record for the Annual Meeting to ensure that all stockholders of record on the record date established by the Board receive the proxy materials.
• The Board has not made any changes to the proposals to be considered by stockholders at the Annual Meeting from the proposals disclosed in the Company's definitive proxy statement filed on April 26, 2024.

Industry Context

This announcement is a routine procedural update related to corporate governance and shareholder meetings. Such postponements due to technical errors are not uncommon, but require prompt communication to maintain investor confidence.

Stakeholder Impact

• Stockholders will need to adjust their schedules to accommodate the new meeting date.
• Stockholders are assured that their votes will be counted and that the meeting will be conducted properly.

Next Steps

• The Company will file updated proxy materials with the SEC.
• The Company will mail updated proxy materials to stockholders of record as of July 24, 2024.
• Stockholders must submit any business proposals or director nominations by June 27, 2024.

Key Dates

Keywords

Annual Meeting, Rhythm Pharmaceuticals, Proxy Statement, Record Date, Stockholders